Daniel M. Halperin, MD

Medical Oncologist and Clinical Investigator

MD Anderson Cancer Center, Houston, Texas


Daniel M. Halperin, MD, will be the featured guest for Luncheon with the Experts on Thursday, February 25, 2021 from 12 noon to 1 pm, Eastern Time.  A medical oncologist and clinical investigator, Dr. Halperin focuses on the development of novel treatments for patients with neuroendocrine tumors (NETs), in addition to providing clinical care to patients with NETs and other gastrointestinal cancers. He leads clinical trials of new drugs for patients with NETs at MD Anderson Cancer Center in Texas, and works with a team of laboratory and population scientists to understand more fully the molecular underpinnings and clinical manifestations of neuroendocrine tumors.

He is also a member of the Neuroendocrine and Adrenal Tumor guideline committee of the National Comprehensive Cancer Network, contributing to evidence-based guidelines for the care of NET patients. Dr. Halperin has a particular interest in the immunology of neuroendocrine tumors and the use of immunotherapy for patients with NETs. As such, he has received peer-reviewed funding from the Neuroendocrine Tumor Research Foundation, as well as a Career Development Award from the American Society of Clinical Oncology, to understand the immunology of NETs and leads a clinical trial of immunotherapy with atezolizumab and bevacizumab for patients with specific rare solid tumors, including two separate cohorts of patients with advanced well-differentiated NETs.


To make an appointment with Dr. Halperin, click here: https://faculty.mdanderson.org/profiles/daniel_halperin.html 

Selected Publications: 

Clinical Trial, Recruiting:


Social Media:

MD Anderson Cancer Center on Twitter, https://twitter.com/MDAndersonNews




Print Friendly, PDF & Email